196 related articles for article (PubMed ID: 30273713)
1. Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges.
Lee E; Sivalingam J; Lim ZR; Chia G; Shi LG; Roberts M; Loh YH; Reuveny S; Oh SK
Biotechnol Adv; 2018 Dec; 36(8):2118-2128. PubMed ID: 30273713
[TBL] [Abstract][Full Text] [Related]
2. Industrially Compatible Transfusable iPSC-Derived RBCs: Progress, Challenges and Prospective Solutions.
Lim ZR; Vassilev S; Leong YW; Hang JW; Rénia L; Malleret B; Oh SK
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575977
[TBL] [Abstract][Full Text] [Related]
3. Generation of Red Blood Cells from Human Pluripotent Stem Cells-An Update.
Lee SJ; Jung C; Oh JE; Kim S; Lee S; Lee JY; Yoon YS
Cells; 2023 Jun; 12(11):. PubMed ID: 37296674
[TBL] [Abstract][Full Text] [Related]
4. [In vitro production of red blood cells for future transfusion medicine].
Kurita R
Rinsho Ketsueki; 2023; 64(6):482-488. PubMed ID: 37407471
[TBL] [Abstract][Full Text] [Related]
5. In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources.
Cho YK; Kim HK; Kwon SS; Jeon SH; Cheong JW; Nam KT; Kim HS; Kim S; Kim HO
Stem Cell Res Ther; 2023 Apr; 14(1):106. PubMed ID: 37101221
[TBL] [Abstract][Full Text] [Related]
6. From stem cells to red blood cells: how far away from the clinical application?
Xie X; Li Y; Pei X
Sci China Life Sci; 2014 Jun; 57(6):581-5. PubMed ID: 24829108
[TBL] [Abstract][Full Text] [Related]
7. Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion.
Ebihara Y; Ma F; Tsuji K
Int J Hematol; 2012 Jun; 95(6):610-6. PubMed ID: 22648827
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine.
Lapillonne H; Kobari L; Mazurier C; Tropel P; Giarratana MC; Zanella-Cleon I; Kiger L; Wattenhofer-Donzé M; Puccio H; Hebert N; Francina A; Andreu G; Viville S; Douay L
Haematologica; 2010 Oct; 95(10):1651-9. PubMed ID: 20494935
[TBL] [Abstract][Full Text] [Related]
9. [Immortalization of erythroid progenitors for in vitro large-scale red cell production].
Caulier A; Guyonneau Harmand L; Garçon L
Transfus Clin Biol; 2017 Sep; 24(3):263-267. PubMed ID: 28736161
[TBL] [Abstract][Full Text] [Related]
10. In-vitro stem cell derived red blood cells for transfusion: are we there yet?
Kim HO
Yonsei Med J; 2014 Mar; 55(2):304-9. PubMed ID: 24532496
[TBL] [Abstract][Full Text] [Related]
11. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.
Baek EJ; Kim HS; Kim S; Jin H; Choi TY; Kim HO
Transfusion; 2008 Oct; 48(10):2235-45. PubMed ID: 18673341
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of human induced pluripotent stem cells into erythroid cells.
Ebrahimi M; Forouzesh M; Raoufi S; Ramazii M; Ghaedrahmati F; Farzaneh M
Stem Cell Res Ther; 2020 Nov; 11(1):483. PubMed ID: 33198819
[TBL] [Abstract][Full Text] [Related]
13. Superior Red Blood Cell Generation from Human Pluripotent Stem Cells Through a Novel Microcarrier-Based Embryoid Body Platform.
Sivalingam J; Lam AT; Chen HY; Yang BX; Chen AK; Reuveny S; Loh YH; Oh SK
Tissue Eng Part C Methods; 2016 Aug; 22(8):765-80. PubMed ID: 27392822
[TBL] [Abstract][Full Text] [Related]
14. Generation of red blood cells from human induced pluripotent stem cells.
Dias J; Gumenyuk M; Kang H; Vodyanik M; Yu J; Thomson JA; Slukvin II
Stem Cells Dev; 2011 Sep; 20(9):1639-47. PubMed ID: 21434814
[TBL] [Abstract][Full Text] [Related]
15. A Scalable Suspension Platform for Generating High-Density Cultures of Universal Red Blood Cells from Human Induced Pluripotent Stem Cells.
Sivalingam J; SuE Y; Lim ZR; Lam ATL; Lee AP; Lim HL; Chen HY; Tan HK; Warrier T; Hang JW; Nazir NB; Tan AHM; Renia L; Loh YH; Reuveny S; Malleret B; Oh SKW
Stem Cell Reports; 2021 Jan; 16(1):182-197. PubMed ID: 33306988
[TBL] [Abstract][Full Text] [Related]
16. Distinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors.
Merryweather-Clarke AT; Tipping AJ; Lamikanra AA; Fa R; Abu-Jamous B; Tsang HP; Carpenter L; Robson KJ; Nandi AK; Roberts DJ
BMC Genomics; 2016 Oct; 17(1):817. PubMed ID: 27769165
[TBL] [Abstract][Full Text] [Related]
17. Ex-vivo generation of human red cells for transfusion.
Anstee DJ; Gampel A; Toye AM
Curr Opin Hematol; 2012 May; 19(3):163-9. PubMed ID: 22406823
[TBL] [Abstract][Full Text] [Related]
18. Intersecting Worlds of Transfusion and Transplantation Medicine: An International Symposium Organized by the Canadian Blood Services Centre for Innovation.
Hodgkinson KM; Kiernan J; Shih AW; Solh Z; Sheffield WP; Pineault N
Transfus Med Rev; 2017 Jul; 31(3):183-192. PubMed ID: 28385575
[TBL] [Abstract][Full Text] [Related]
19. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo.
Neildez-Nguyen TM; Wajcman H; Marden MC; Bensidhoum M; Moncollin V; Giarratana MC; Kobari L; Thierry D; Douay L
Nat Biotechnol; 2002 May; 20(5):467-72. PubMed ID: 11981559
[TBL] [Abstract][Full Text] [Related]
20. Production of erythroid cells from human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPS).
Anstee DJ
Transfus Clin Biol; 2010 Sep; 17(3):104-9. PubMed ID: 20655785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
